Cargando…
Recent Advances in Targeted Nanocarriers for the Management of Triple Negative Breast Cancer
Triple-negative breast cancer (TNBC) is a life-threatening form of breast cancer which has been found to account for 15% of all the subtypes of breast cancer. Currently available treatments are significantly less effective in TNBC management because of several factors such as poor bioavailability, l...
Autores principales: | Pradhan, Rajesh, Dey, Anuradha, Taliyan, Rajeev, Puri, Anu, Kharavtekar, Sanskruti, Dubey, Sunil Kumar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9866847/ https://www.ncbi.nlm.nih.gov/pubmed/36678877 http://dx.doi.org/10.3390/pharmaceutics15010246 |
Ejemplares similares
-
Advancements in Polymeric Nanocarriers to Mediate Targeted Therapy against Triple-Negative Breast Cancer
por: Fatima, Mahak, et al.
Publicado: (2022) -
Recent advances in managing triple-negative breast cancers
por: Bengala, Carmelo
Publicado: (2009) -
Triple-negative breast cancer: recent treatment advances
por: Bergin, Alice R T, et al.
Publicado: (2019) -
Recent advances in triple negative breast cancer: the immunotherapy era
por: Marra, Antonio, et al.
Publicado: (2019) -
Recent advances in nanotheranostics for triple negative breast cancer treatment
por: Thakur, Vikram, et al.
Publicado: (2019)